Virginia Venture
Herndon, Virginia, United States, North America
Overview
Virginia Venture Partners is a family of seed-stage investment funds placing near-equity and equity investments in Virginia-based technology, life science, and cleantech companies. Virginia Venture Partners invests in companies with a high potential for achieving rapid growth and generating significant economic returns for entrepreneurs, co-investors, and the Commonwealth of Virginia. CIT’s family of funds includes: GAP Fund I is a vintage 2004 fund fully invested in a broad array of seed-stage technology companies. Portfolio. GAP BioLife Fund is a seed fund investing exclusively in life science companies. GAP Tech Fund is a seed fund investing in IT and technology companies.
- Total investments
- 1
- Lead investments
- 1
- Investments · 12mo
- 1
- Active investors
- 4
Sector focus
- Finance
- Information Technology
Investment portfolio
- Trase
Led · Seed · Nov 2025
Trase offers an agentic operating system, Trase Origin, and a suite of hundreds of deployable AI agents designed for high-stakes, regulated environments with requirements for security, governance, and auditability. The platform supports deployment across cloud, on-prem, or edge environments and includes features such as data sovereignty, reinforcement learning from human feedback, continuous monitoring, immutable audit trails, and a judgment layer to route decisions to humans when appropriate. Trase is HIPAA and SOC2 compliant and reports live deployments at Duke University Health System, where its fax routing agent reportedly processes faxes 7.1x faster than manual routing, saves 1,395 staff hours per month, and unlocks $285,450 in annual staff capacity. The company launched publicly last fall, has grown to 55 employees with hubs in Seattle and the Washington, D.C., metro area, and is headquartered in McLean, Va. Following its $107M Seed raise, Trase plans to expand its go-to-market team and continue development of its operating system and agent ecosystem.